HUH, so the news that UNS has been talking about for 4 months is an announcement of 5 million revenue (covers 6 weeks operating costs) and then over a 4 year period they will ramp up production to meet the requirements of Sanofi. IF, that is IF Sanofi want to maintain exclusive use of the Unifill for this drug product/area then they have to order 150million units annually.
Yet its the shorters controlling the SP. UNS have not really deliverd a lot and I hope he has more in store over the next few days, but I doubt it!!!!
The kick off date was not mentioned? Seems a no brainer to release it. The fact they didnt means what? Who knows, but suspect it means could still be months away. Could be extended to 2024? So after a 4 year ramp up how long is the actual supply period?
Its is a rather beige announcement after all the hoo-hah and my being mega disappointed (and I had low expectations) seems to be reflected in the poor rise in US and fall locally.
- Forums
- ASX - By Stock
- UNS
- $$1bn dollar contract with $96 bn pharma
$$1bn dollar contract with $96 bn pharma, page-24
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online